10-Q: Mativ Holdings Reports Q3 Loss Narrows, But 9-Month Results Hit by $412M Goodwill Impairment

Mativ Holdings, Inc. reported a narrower net loss for the third quarter of 2025, but a significant goodwill impairment in its Filtration & Advanced Materials segment led to a substantial net loss for the first nine months of the year.

Summary

• Net sales for the three months ended September 30, 2025, increased by 3.0% to $513.7 million, up from $498.5 million in the prior-year quarter.
• Net sales for the nine months ended September 30, 2025, saw a slight increase of 0.1% to $1,523.9 million, compared to $1,522.5 million in the same period last year.
• The company reported a net loss of $3.2 million, or $(0.06) per diluted share, for the third quarter of 2025, a significant improvement from the $20.8 million net loss, or $(0.38) per diluted share, in Q3 2024.
• For the nine months ended September 30, 2025, Mativ recorded a net loss of $438.2 million, or $(8.04) per diluted share, primarily due to a $411.9 million goodwill impairment charge in the first quarter.
• Operating profit for Q3 2025 was $16.0 million, an increase from $7.0 million in Q3 2024, driven by improved performance in the Sustainable & Adhesive Solutions (SAS) segment.
• The Filtration & Advanced Materials (FAM) segment experienced a 42.7% decrease in operating income for Q3 2025, falling to $11.4 million from $19.9 million in Q3 2024, due to higher restructuring and manufacturing costs.
• Cash provided by operating activities for the nine months ended September 30, 2025, increased to $114.5 million from $70.7 million in the prior-year period, attributed to favorable working capital movements and lower restructuring cash payments.
• Total debt stood at $1,028.9 million as of September 30, 2025, with a net leverage ratio of 4.2x, remaining within the maximum covenant ratio of 5.50x.
• The Receivables Sales Agreement was amended on November 5, 2025, extending its term to November 5, 2026, and reducing the maximum funding commitment from $175.0 million to $150.0 million.
• Mativ announced a cash dividend of $0.10 per share payable on December 19, 2025, to stockholders of record as of November 28, 2025.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the substantial goodwill impairment of $411.9 million, which resulted in a significant net loss for the nine-month period. While Q3 showed some operational improvements and a narrower net loss, the overall financial health, as reflected by the nine-month results and the reduction in stockholders' equity, is concerning. The reduction in the receivables sales agreement commitment also adds a minor negative note regarding liquidity flexibility.

Positives

• Net loss for Q3 2025 significantly narrowed to $3.2 million from $20.8 million in Q3 2024.
• Operating profit for Q3 2025 increased to $16.0 million from $7.0 million in Q3 2024.
• The Sustainable & Adhesive Solutions (SAS) segment showed strong improvement, with operating income increasing by $18.1 million in Q3 2025, driven by lower restructuring expenses, favorable net selling price versus input costs, and reduced manufacturing and selling/general expenses.
• Cash provided by operating activities for the nine months ended September 30, 2025, improved to $114.5 million from $70.7 million in the prior-year period.
• The company remains in compliance with all debt covenants, with a net leverage ratio of 4.2x against a maximum of 5.50x.
• Restructuring and other impairment expenses decreased to $8.1 million in Q3 2025 from $11.2 million in Q3 2024, and to $18.2 million for the nine months from $37.4 million in the prior year.

Negatives

• A substantial non-cash goodwill impairment charge of $411.9 million was recognized in the first quarter of 2025, fully impairing the goodwill attributable to the FAM reporting unit.
• The goodwill impairment led to a significant net loss of $438.2 million for the nine months ended September 30, 2025, compared to a $50.2 million net loss in the prior-year period.
• Diluted loss per share for the nine months ended September 30, 2025, was $(8.04), a substantial increase from $(0.93) in the prior-year period.
• Total stockholders' equity decreased significantly to $397.4 million as of September 30, 2025, from $858.5 million at December 31, 2024, largely due to the net loss.
• The FAM segment's operating income decreased by 42.7% in Q3 2025, primarily due to higher restructuring and other impairment expenses and increased manufacturing costs.
• Gross profit for the nine months ended September 30, 2025, decreased by 3.8% to $275.7 million, reflecting higher manufacturing and distribution costs.
• The maximum funding commitment under the Receivables Sales Agreement was reduced from $175.0 million to $150.0 million.

Risks

• Risks associated with the implementation of strategic growth initiatives, including diversification into new industries and technologies.
• Risks related to acquisitions, dispositions, strategic transactions, and global asset realignment initiatives.
• Adverse changes in end-market sectors impacting key customers.
• Changes in the source and intensity of competition in commercial end-markets.
• Adverse changes in sales or production volumes, pricing, and/or manufacturing costs.
• Seasonal or cyclical market and industry fluctuations leading to reduced net sales and operating profits.
• Risks associated with technological advantages in intellectual property and the potential inability to maintain these advantages indefinitely.
• Supply chain disruptions, including the failure of material suppliers (energy, resin, fiber, chemicals).
• Increases in operating costs due to inflation, labor expense, compensation, and benefits.
• Ability to attract and retain key personnel, labor shortages, strikes, stoppages, or other disruptions.
• Changes in general economic, financial, and credit conditions, including impacts on currency exchange rates and interest rates.
• Failure in risk management, currency, or interest rate swaps and hedging programs, including counterparty failures.
• Changes in the manner of debt financing and future capital needs, including for potential acquisitions.
• Changes in tax rates, new tax legislation, or exposure to additional tax liabilities.
• Uncertainty regarding the long-term value of Mativ common stock.
• Changes in employment, wage, and hour laws and regulations, including unionization rules and anti-discrimination rules.
• Impact of tariffs, imposition of future tariffs, trade barriers, retaliatory trade measures, and tariff uncertainty on macroeconomic conditions.
• Existing and future governmental regulation and enforcement that may restrict business and financial results.
• Weather conditions, climate change impacts, natural disasters, or unusual weather events.
• International conflicts and disputes (e.g., Russia-Ukraine, Israel-Hamas) restricting product supply, affecting demand, and impacting commercial activities.
• Compliance with FCPA, anti-corruption laws, trade control laws, and other operational laws.
• Risks associated with pandemics and other public health emergencies.
• Number, type, outcomes, and costs of legal, tax, regulatory, or administrative proceedings and litigation.
• Increased scrutiny from stakeholders regarding environmental, social, and governance (ESG) matters and the ability to achieve ESG goals.
• Costs and timing of implementing upgrades or changes to information technology systems.
• Failure to comply with privacy or data security laws or to protect against theft of sensitive information.
• Information technology system failures, data security breaches, network disruptions, and cybersecurity events.

Future Outlook

The company expects to record additional restructuring costs in the FAM segment, not exceeding $0.5 million, related to a facility closure during the fourth quarter of 2025. The impact of the 'One Big Beautiful Bill Act' on income tax expense for 2025 is not expected to be material. Management believes current liquidity sources will be sufficient to finance continued operations, growth plans, and dividend payments for the foreseeable future. The ability to achieve forecasted cash flows in the SAS segment may be negatively impacted by deteriorating economic conditions, market fluctuations, adverse changes in end-market sectors, and tariffs.

Management Comments

• Management believes that the ultimate disposition of current legal proceedings will not have a material effect on the results of operations in a given quarter or year.
• Management believes that future costs of compliance with environmental laws and regulations, and exposure to liability for environmental claims, will not have a material effect on financial condition or results of operations, though future events could change this.

Industry Context

The company operates in specialty materials, serving diverse end-markets from filtration to healthcare and sustainable packaging. The significant goodwill impairment in the FAM segment, which focuses on high-growth end markets, suggests a re-evaluation of market conditions or the company's competitive position within those segments. The SAS segment, serving both growing and mature markets, showed resilience and improved operating profit, indicating a more stable performance in its diversified portfolio. The mention of U.S. government tariffs and potential retaliatory measures highlights broader macroeconomic and trade policy challenges impacting global manufacturing and supply chains.

Comparison to Industry Standards

• NA

Legal Proceedings

• The company is involved in various legal proceedings from time to time, including relating to contracts, commercial disputes, taxes, environmental issues, employment and workers' compensation claims, product liability, and other matters.
• Management believes that the ultimate disposition of these matters will not have a material effect on the results of operations in a given quarter or year.

Stakeholder Impact

• Shareholders: Significant net loss and diluted EPS for the nine months, coupled with a substantial decrease in total stockholders' equity, will negatively impact shareholder value. The announced dividend provides some return, but is overshadowed by the impairment.
• Employees: The ongoing organizational realignment initiative and facility closures indicate potential job impacts and changes in workforce structure.
• Creditors: The company remains in compliance with debt covenants, which is positive for creditors, but the goodwill impairment could raise concerns about asset backing and future profitability.
• Customers: Operational improvements in the SAS segment and continued focus on specialty materials aim to enhance customer support and product offerings.

Next Steps

• Record additional restructuring costs in the FAM segment, not exceeding $0.5 million, related to a facility closure during Q4 2025.
• Continue to assess the dividend policy in light of overall strategy, cash generation, debt levels, and ongoing cash requirements.
• Monitor advancements and further guidance in Pillar Two tax rules and evaluate their impact on tax expense.
• Evaluate the impact of ASU 2024-03 (Expense Disaggregation Disclosures) on disclosures, effective after December 15, 2026.
• Evaluate the impact of ASU 2025-05 (Credit Losses for Accounts Receivable) on consolidated financial statements, effective after December 15, 2025.
• Evaluate the impact of ASU 2025-06 (Goodwill and Other Internal-Use Software) on consolidated financial statements, effective after December 15, 2027.

Key Dates

Recommendation

The significant goodwill impairment of $411.9 million for the nine months ended September 30, 2025, resulting in a substantial net loss, is a major negative that reflects a re-evaluation of the value of the Filtration & Advanced Materials segment. While the third quarter showed some operational improvements and a narrower net loss, these are largely overshadowed by the nine-month performance. The company maintains compliance with debt covenants and has improved cash from operations, indicating some underlying stability. However, the long-term implications of the impairment and ongoing market uncertainties warrant caution. A 'hold' recommendation is appropriate as investors should monitor the company's ability to execute its restructuring plan, stabilize the FAM segment, and demonstrate sustained profitability before considering further investment, while existing investors might hold to see if the Q3 operational improvements can be sustained and translate into a recovery.

Keywords

Specialty Materials, Filtration, Advanced Materials, Sustainable Solutions, Adhesive Solutions, Goodwill Impairment, SEC Filing, 10-Q, Financial Results, Net Loss, Operating Profit, Debt, Liquidity, Tariffs, Pension Plans, Restructuring, MATV